| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MRNS | Common Stock | Gift | $0 | -4.98K | -26.3% | $0.00 | 14K | Oct 10, 2024 | By Trust | F3, F4 |
| transaction | MRNS | Common Stock | Gift | $0 | -1.66K | -11.89% | $0.00 | 12.3K | Oct 10, 2024 | By Trust | F3, F5 |
| transaction | MRNS | Common Stock | Gift | $0 | -1.66K | -13.5% | $0.00 | 10.6K | Oct 10, 2024 | By Trust | F3, F6 |
| holding | MRNS | Common Stock | 25.8K | Oct 10, 2024 | Direct | F1 | |||||
| holding | MRNS | Common Stock | 6.9K | Oct 10, 2024 | Direct | F2 | |||||
| holding | MRNS | Common Stock | 18.9K | Oct 10, 2024 | By Trust | F2, F3 | |||||
| holding | MRNS | Common Stock | 1.66K | Oct 10, 2024 | By Trust | F5 | |||||
| holding | MRNS | Common Stock | 1.66K | Oct 10, 2024 | By Trust | F6 |
| Id | Content |
|---|---|
| F1 | The reported amount reflects an adjustment to correct a clerical error that previously underreported the Reporting Person's holdings by 1,462 shares of Marinus Pharmaceuticals, Inc. (the "Issuer") common stock. No reportable transactions were omitted from previous filings in connection with the clerical error underlying this correction. |
| F2 | The reported amounts reflect an adjustment to correct an administrative error that previously reported that all of the Reporting Person's holdings in Issuer common stock were owned directly by the Reporting Person. Such amounts have been corrected to reflect shares of Issuer common stock held by the Reporting Person directly (i.e., 6,900 shares underlying restricted stock units) and those held by the Timothy M. Mayleben Revocable Trust U/A/D 9/16/16 (i.e., 18,937 shares), of which the Reporting Person is the sole trustee. |
| F3 | Represents shares of Issuer common stock held by the Timothy M. Mayleben Revocable Trust U/A/D 9/16/16, of which the Reporting Person is the sole trustee. |
| F4 | On October 10, 2024, the Reporting Person transferred an aggregate of 4,980 shares of Issuer common stock from the Timothy M. Mayleben Revocable Trust U/A/D 9/16/16 to members of the Reporting Person's immediate family who do not share the Reporting Person's household for no consideration. |
| F5 | On October 10, 2024, the Reporting Person transferred 1,660 shares of Issuer common stock from the Timothy M. Mayleben Revocable Trust U/A/D 9/16/16 to the Ellery A. Mayleben 2017 Trust for no consideration. The Reporting Person is trustee of the trust, and a member of his immediate family is the sole beneficiary of the trust. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose |
| F6 | On October 10, 2024, the Reporting Person transferred 1,660 shares of Issuer common stock from the Timothy M. Mayleben Revocable Trust U/A/D 9/16/16 to the Kasey D. Evans 2017 Trust for no consideration. The Reporting Person is trustee of the trust, and a member of his immediate family is the sole beneficiary of the trust. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. |